THEM6-mediated reprogramming of lipid metabolism supports treatment resistance in prostate cancer. (2022)

First Author: Blomme A

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.15252/emmm.202114764

PubMed Identifier: 35014179

Publication URI: http://europepmc.org/abstract/MED/35014179

Type: Journal Article/Review

Volume: 14

Parent Publication: EMBO molecular medicine

Issue: 3

ISSN: 1757-4676